Table 6. Cytogenetic risk status by... | American Society of Hematology

Table 6.

Cytogenetic risk status by postremission treatment arm

Risk status	Allogeneic BMT		Autologous BMT		Consolidation		No postremission treatment on study		Total
Risk status	No.	%	No.	%	No.	%	No.	%	No.	%
Favorable	19	23	26	31	22	23	31	21	98	25
Intermediate	47	56	37	45	44	51	77	53	205	51
Unfavorable	18	21	20	24	20	26	38	26	96	24
Total Known	84	100	83	100	86	100	146	100	399	100
Unknown	5	—	1	—	4	—	3	—	13	—
Total	89	—	84	—	90	—	149	—	412	—

Risk status	Allogeneic BMT		Autologous BMT		Consolidation		No postremission treatment on study		Total
Risk status	No.	%	No.	%	No.	%	No.	%	No.	%
Favorable	19	23	26	31	22	23	31	21	98	25
Intermediate	47	56	37	45	44	51	77	53	205	51
Unfavorable	18	21	20	24	20	26	38	26	96	24
Total Known	84	100	83	100	86	100	146	100	399	100
Unknown	5	—	1	—	4	—	3	—	13	—
Total	89	—	84	—	90	—	149	—	412	—

BMT indicates bone marrow transplantation.